Program

08:30-09:15
Registration
 
09:15-09:30
Welcome notes
 
09:30-12:10
Adaptation I
Chair: Udi Qimron 
09:30-10:00
Peter Fineran, University of Otago
Spacer capture and integration during adaptation in the type I-F CRISPR-Cas system
10:00-10:30
Konstantin Severinov, Rutgers University
A causal relationship between CRISPR interference and primed adaptation
10:30-11:00
Coffee Break
11:00-11:30
Edward Bolt , University of Nottingham
Protospacer Capture and Integration by E. coli Cas1-Cas2 Exploits DNA Replication Surveillance Systems
11:30-11:50
MaryClare Rollins, Montana State University
The RNA-guided surveillance complex is a master regulator of the immune response
11:50-12:10
Raymond Staals, University of Otago
Interference dominates and amplifies spacer acquisition in a native CRISPR-Cas system
12:10-14:00
Lunch
 
14:00-15:30
Adaptation II
Chair: Konstantin Severinov 
14:00-14:30
Stan Brouns, Wageningen University
Insights into the mechanism of primed memory formation
14:30-14:50
Alexander Hynes, Universite Laval
Programmed acquisition reveals new features of CRISPR-Cas adaptation
14:50-15:10
Dipali Sashital, Iowa State University
Promiscuous PAM recognition underpins a two-tiered adaptation strategy
15:10-15:30
Coffee Break
15:30-17:10
Type III
Chair: Michael Terns 
15:30-16:00
Virginjus Siksnys, Vilnius University
Spatio-temporal control of Streptococcus thermophilus Type III-A CRISPR-Cas immunity
16:00-16:20
Walter Woodside, University of Georgia
Bipartite Recognition of Target RNAs Activates DNA Cleavage by the Type III-B Cmr CRISPR-Cas System
16:20-16:50
Scott Bailey, Johns Hopkins University
DNA cleavage by the Type III-B CRISPR-Cas system
16:50-17:10
Wenyan Jiang, Rockefeller University
Degradation of Phage Transcripts by CRISPR-associated RNases Enables Type III CRISPR-Cas Immunity
17:10-20:00
Poster session and dinner
 
09:00-11:50
Type I
Chair: John van der Oost 
09:00-09:30
Lennart Randau, MPI Marburg
Modulation of minimal Cascade assemblies
09:30-10:00
Blake Wiedenheft, Montana State University
The best offense is a good defense: understanding genetic conflict at near-atomic resolution
10:00-10:20
Ilya Finkelstein, The University of Texas at Austin
Massively parallel analysis of Cascade-DNA interactions reveals the biophysical mechanisms of DNA targeting by the Type I-E CRISPR system
10:20-11:00
Coffee Break
11:00-11:30
Ailong Ke, Cornell University
Directional R-loop formation mechanism in Type I-E Cascade and its implications in Cas3 recruitment and activation
11:30-11:50
Israela Turgeman Grott, Tel Aviv University
Inter-species targeting by the CRISPR-Cas system in halophilic archaea
11:50-12:30
Industry
Chair: Rodolphe Barrangou 
11:50-12:10
Tom Barnes, Intellia
Translating CRISPR/Cas9 into Therapeutic Reality
12:10-12:30
Hari Jayaram, Editas
Advancing CRISPR-based Medicines
12:30-15:00
Lunch and poster session
 
15:00-17:45
Type II
Chair: Erik Sontheimer 
15:00-15:30
John van der Oost, Wageningen University
EMBO Keynote Lecture
CRISPR-Cas class-2 effector complexes- from biology to applications
15:30-16:00
Emmanuelle Charpentier, MPI Berlin
Class II CRISPR-Cas systems in bacteria: comparative analysis of Cas9- and Cpf1-mediated mechanisms
16:00-16:15
Coffee Break
16:15-16:45
Rodolphe Barrangou , North Carolina State University
Characterization of diverse Type II CRISPR-Cas systems
16:45-17:15
David Bikard, Pasteur Institute
Interactions between DNA repair pathways and CRISPR-Cas systems
17:15-17:45
Feng Zhang, MIT
Exploring the CRISPR diversity for novel genome editing tools
17:45-18:15
Transportation to Tel Aviv
 
18:30-22:30
Free evening in Tel Aviv
 
09:00-10:00
Keynote Lecture
 
09:00-10:00
Jennifer Doudna, UC Berkeley
CRISPR Systems: Biology, Technology and Ethics
10:00-12:20
Type II
Chair: Blake Wiedenheft 
10:00-10:30
Sylvain Moineau, Laval University
CRISPR-Cas in the classroom
10:30-11:00
Coffee Break
11:00-11:30
Chase Beisel, North Carolina State University
Navigating the CRISPR PAM: tools to identify and visualize DNA recognition requirements across CRISPR-Cas systems
11:30-12:00
Martin Jinek, University of Zurich
Structural insights into the interference mechanisms of type II and type III-A CRISPR-Cas systems
12:00-12:20
Aris Stachler, Ulm University
Gene repression in Archaea using CRISPR-Cas
12:20-14:00
Lunch
 
14:00-17:00
Ecology & Evolution
Chair: Eugene Koonin 
14:00-14:30
Alan Davidson, University of Toronto
The dark side of CRISPR-Cas: the anti-CRISPR force awakens
14:30-15:00
Erik Sontheimer, University of Massachusetts
Neisseria meningitidis Cas9, CRISPR Interference, and Genome Editing
15:00-15:20
Edze Westra, University of Exeter
The diversity-generating benefits of a prokaryotic adaptive immune system
15:20-15:40
Coffee Break
15:40-16:00
Nina Molin Hoeyland-Kroghsbo, Princeton University
Quorum sensing regulation of the CRISPR-Cas adaptive immune system in Pseudomonas aeruginosa
16:00-16:30
Eugene Koonin, NIH/NCBI
Discovery of novel CRISPR-Cas systems by genome and metagenome sequence database mining and evolution of adaptive immunity in prokaryotes
16:30-17:00
Rotem Sorek, Weizmann Institute of Science
Beyond CRISPR: Phage-bacteria interactions in the wild
17:00-17:10
Concluding remarks
 
19:00-22:00
Dinner
 
08:00-18:00
Tour to the Dead Sea and Jerusalem